Vermont H0676 aims to ensure continued access to animal-derived thyroid medications for patients in Vermont.

Vermont H0676 directs the Office of Professional Regulation to explore and implement options to maintain patient access to animal-derived thyroid medications, such as desiccated thyroid extract. The Office must consult with health care professionals, insurers, patients, and other stakeholders. It must report findings and recommendations to the General Assembly by January 15, 2027, including any options requiring legislative action. The bill emphasizes ensuring these medications remain available for patients who find them more effective or better tolerated than synthetic alternatives.

Vermont H0676 aims to ensure continued access to animal-derived thyroid medications for patients in Vermont.

Vermont H0676 directs the Office of Professional Regulation to explore and implement options to maintain patient access to animal-derived thyroid medications, such as desiccated thyroid extract. The Office must consult with health care professionals, insurers, patients, and other stakeholders. It must report findings and recommendations to the General Assembly by January 15, 2027, including any options requiring legislative action. The bill emphasizes ensuring these medications remain available for patients who find them more effective or better tolerated than synthetic alternatives.